MedPath
FDA Approval

OLOPATADINE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
May 7, 2019
Labeling Type
Human Prescription Drug Label
Olopatadine(2 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Gland Pharma Limited

Alembic Pharmaceuticals Inc.

918601238

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

OLOPATADINE HYDROCHLORIDE

Product Details

NDC Product Code
62332-502
Application Number
ANDA209420
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
April 29, 2019
Code: 2XG66W44KFClass: ACTIMQuantity: 2 mg in 1 mL
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74Class: IACT
© Copyright 2025. All Rights Reserved by MedPath